AIG
FMTX

American International Group’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

American International Group’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,172
Closed -$343K – 3048
2022
Q3 		$343K Buy
17,172
+242
+1% +$3.19K ﹤0.01% 1821
2022
Q2 		$117K Buy
16,930
+67
+0.4% +$470 ﹤0.01% 2513
2022
Q1 		$157K Sell
16,863
-1,188
-7% -$12.6K ﹤0.01% 2388
2021
Q4 		$257K Sell
18,051
-540
-3% -$9.34K ﹤0.01% 2219
2021
Q3 		$431K Buy
18,591
+574
+3% +$13.6K ﹤0.01% 1963
2021
Q2 		$448 Buy
18,017
+402
+2% +$10.8K ﹤0.01% 1989
2021
Q1 		$494 Buy
17,615
+7,619
+76% +$275K ﹤0.01% 1848
2020
Q4 		$349 Buy
9,996
+358
+4% +$15.6K ﹤0.01% 1963
2020
Q3 		$480K Buy
+9,638
New +$390K ﹤0.01% 1607

American International Group's FMTX Position: Q4 2022 in Review

American International Group sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 17,172 shares — an estimated $343K sold.

American International Group first reported a position in FMTX in Q3 2020 and held it in 9 quarters. The position peaked at $480K in Q3 2020. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • American International Group reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • American International Group sold 17,172 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $343K.
  • American International Group first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • American International Group's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $480K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on American International Group's 13F filing for Q4 2022, filed 10 Feb 2023.